22 Mar 2019 - After opening higher this morning following strong leads from Wall Street the ASX 200 saw an early rally, peaked just after midday and has been slowly easing off over the afternoon to end 0.5 per cent higher at 6,195. The majority of sectors made headway with Healthcare maintaining the lead throughout the day.
22 Mar 2019 - Australian Banking Association CEO Anna Bligh discusses the aftermath of the Royal Banking Commission, bank staff pay and how the sector can drive cultural change.
22 Mar 2019 - The S&P/ASX 200 opened higher this morning following strong leads from Wall Street where US equities reached a five-month high. The market continues to rally into the middle of the session with every sector making ground this morning. Healthcare led the charge thanks to very strong results from Sienna Cancer Diagnostics (ASX:SDX) and Imugene (ASX:IMU).
22 Mar 2019 - The board of Corporate Travel Management (ASX:CTD) has announced that Ewen Crouch will take over from Tony Bellas as chairman. Mr Crouch is currently a director of Westpac Banking Corporation (ASX:WBC) and a director of BlueScope Steel (ASX:BSL).
22 Mar 2019 - Retailing, importing and distributing major, Premier Investments (ASX:PMV) has released its half year results for the period ending 26 January 2019. It delivered net profit after tax of $88.8 million. That is up 13 per cent on the prior corresponding period.
22 Mar 2019 - Insurance and banking services provider Suncorp (ASX:SUN) are set to pay a fully franked special dividend of 8 cents per share on 3 May 2019. The dividend will follow the successful completion of the sale of its Australian Life Business to TAL Dai-ichi Life Australia.
22 Mar 2019 - The Australia and New Zealand Banking Group (ASX:ANZ) has completed its $3 billion share buyback. 108.7 million ordinary shares were purchased under the program. This equates to a reduction of approximately 3.7 per cent in ordinary shares on issue.
22 Mar 2019 - Gold company St Barbara (ASX:SBM) has completed their feasibility study for their Gwalia Mass Extraction project.
22 Mar 2019 - Biotechnology company Immutep (ASX:IMM) has received the grant of a new patent from the United States Patent Office for eftilagimod alpha in cancer.
22 Mar 2019 - The ASX is poised to open higher. In the US equities reached a five-month high. Tech shares rallied. Over in the UK, the Bank of England held interest rates steady as the date for Britain to leave the EU is still uncertain. Education provider Navitas (NVT:ASX) has accepted a $2.3b takeover bid from private equity player BGH Consortium.